<ARTICLE> 5 <LEGEND> This schedule contains second quarter and six months year-to-date summary financial information extracted from Abbott Laboratories 1995 second quarter 10-Q and is qualified in its entirety by reference to such Form 10-Q filing. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1995 <PERIOD-START> JAN-01-1995 <PERIOD-END> JUN-30-1995 <CASH> 254,395 <SECURITIES> 56,463 <RECEIVABLES> 1,673,832 <ALLOWANCES> 155,059 <INVENTORY> 1,094,764 <CURRENT-ASSETS> 4,040,131 <PP&E> 7,544,199 <DEPRECIATION> 3,391,117 <TOTAL-ASSETS> 8,990,323 <CURRENT-LIABILITIES> 3,535,061 <BONDS> 435,730 <COMMON> 546,974 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <OTHER-SE> 3,696,235 <TOTAL-LIABILITY-AND-EQUITY> 8,990,323 <SALES> 5,024,707 <TOTAL-REVENUES> 5,024,707 <CGS> 2,174,934 <TOTAL-COSTS> 2,174,934 <OTHER-EXPENSES> 534,535<F1> <LOSS-PROVISION> 41,871 <INTEREST-EXPENSE> 31,804 <INCOME-PRETAX> 1,193,311 <INCOME-TAX> 352,027 <INCOME-CONTINUING> 841,284 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 841,284 <EPS-PRIMARY> 1.05 <EPS-DILUTED> 1.04 <FN> <F1>OTHER EXPENSES CONSIST OF RESEARCH AND DEVELOPMENT EXPENSES